Last reviewed · How we verify
sevelamer hydrochloride, sevelamer carbonate — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
sevelamer hydrochloride, sevelamer carbonate (sevelamer hydrochloride, sevelamer carbonate) — Genzyme, a Sanofi Company.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| sevelamer hydrochloride, sevelamer carbonate TARGET | sevelamer hydrochloride, sevelamer carbonate | Genzyme, a Sanofi Company | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- sevelamer hydrochloride, sevelamer carbonate CI watch — RSS
- sevelamer hydrochloride, sevelamer carbonate CI watch — Atom
- sevelamer hydrochloride, sevelamer carbonate CI watch — JSON
- sevelamer hydrochloride, sevelamer carbonate alone — RSS
Cite this brief
Drug Landscape (2026). sevelamer hydrochloride, sevelamer carbonate — Competitive Intelligence Brief. https://druglandscape.com/ci/sevelamer-hydrochloride-sevelamer-carbonate. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab